Navigation Links
EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting

nical development for the treatment of obesity and cognitive impairment. The company also has a blood-pool imaging agent (Vasovist(TM)) approved in 32 countries and marketed in Europe. EPIX has collaborations with leading organizations, including GlaxoSmithKline, Amgen, Cystic Fibrosis Foundation Therapeutics, and Bayer Schering Pharma AG, Germany. For more information, please visit the company's website at www.epixpharma.com.

This news release contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, that are based on current expectations of management. These statements relate to, among other things, our expectations regarding the progress, timing and results of our clinical development program for PRX-00023 and other drug candidates. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: risks that product candidates, including PRX-00023, may fail in the clinic or may not be successfully marketed or manufactured; risks relating to our ability to advance the development of product candidates currently in the pipeline or in clinical trials, any failure to comply with regulations relating to our products and product candidates, including FDA requirements; failure to obtain the financial resources to complete development of product candidates; the risk that the FDA may interpret the results of our studies differently than we have; competing products may be more successful; our inability to interest potential partners in our technologies and products; our inability to achieve commercial success for our products and technologies; the possibility of delays in the research and development necessary to select drug
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:7/11/2014)... -- On Thursday, July 10, 2014, ... Jones Industrial Average finished the day 0.42% lower at 16,915.07, ... losses were broad based as eight out of ten sectors ... Sector Index ended the day at 711.88, down 0.02%, while ... Investor-Edge has initiated coverage on the following equities: Covidien PLC ...
(Date:7/11/2014)... , July 11, 2014  Veran Medical ... announced today the positive, cost-effective final results ... SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy ... percutaneous approach to biopsy when a traditional ... and physicians experience positive financial outcomes when ...
(Date:7/10/2014)... MUMBAI, India , July 11, 2014 /PRNewswire/ ... the treatment of cancer are being highlighted in ... Mumbai from 10-12 July, 2014.  Renowned ... meeting to share best practices and exchange knowledge ... more precise, accurate and efficient. ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Veran Medical Publishes Lung Cancer Patient Management Study 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... Aug. 22, 2011 Reportlinker.com announces ... is available in its catalogue: ... Strategic Assessments of Leading Suppliers ... This report provides diagnostic imaging ...
... Santosh Nanda, Microbiologist/ Primary Reviewer, CBER, FDA ... have announced their official participation at the Viral ... the 17th October to 19th October 2011 in NH ... has expanded its focus from solely viral safety to ...
Cached Medicine Technology:Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 2Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 3Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 4Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers 5Food and Drug Administration (FDA) Joins Pharma IQ's Viral Safety 2011 Conference 2
(Date:7/12/2014)... Pittsburgh, PA (PRWEB) July 12, 2014 ... embarrassing, so one of two inventors from Ashland, Va., ... to do this. "This inspired us to conceive of ... prototype of the patent-pending KIDNEY KOVER, which provides an ... bag. It avoids embarrassment, as well as promotes comfort ...
(Date:7/12/2014)... With prom shopping reaching its final days, VogueQueen.com, ... to showcase its new and trendy apparels. Recently, the ... in its online shop. Additionally, it is now providing ... gowns. According to the company’s sales manager, the promotion ... , He says, “Now, worldwide clients can order ...
(Date:7/12/2014)... 2014 Wright & Schulte LLC has filed ... Inc., a subsidiary of Johnson & Johnson, on behalf of ... after receiving a metal-on-metal DePuy Pinnacle hip replacement and had ... artificial hip implant. The DePuy hip lawsuit was filed July ... Texas (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit ...
(Date:7/12/2014)... Warminster, PA (PRWEB) July 12, 2014 ... Paddock covering a variety of men’s health questions. ... issues specific to men, why women live longer than ... article, Men's Health Made Simple featured on ... can get a hernia at any age. If you ...
(Date:7/12/2014)... 12, 2014 Utah Valley Entrepreneurial Forum ... with awards being bestowed to companies in revenue, and ... entrepreneur community with recognition for new ideas as well ... incoming revenue. , 25 Under 5 highlights outstanding Utah ... are under 5 years old. Award recipients were recognized ...
Breaking Medicine News(10 mins):Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2Health News:SquareHook is Recognized for UVEF 25 Businesses Under 5 Years-Watch Out 2
... findings of a study carried out at Hammersmith hospital reveal ... as effective at protecting women from developing cervical abnormalities as ... Professor Jack Cuzick of Barts and The London School of ... 2008) in the International Journal of Cancer. , Nearly 3,000 ...
... NEW YORK, May 14 The F.A.C.E. ... help connect and empower African-Americans,to take a ... report from Eli Lilly and Company at:, ... video, audio, text, graphics and,photos for free ...
... Cancellation Lawsuits Contributed,$804,600 to Governor, SANTA MONICA, Calif., ... industry insiders the state,s top HMO,regulator is considering a ... paying for past medical bills for some patients whose ... is also rumored to include,provisions designed to limit Kaiser,s ...
... Danny Diaz released the following statement today:, "Barack ... by Congress raises serious doubts about his understanding of,what ... actually is. His refusal,to enforce the law reveals that ... job of President, or that he fundamentally lacks the,judgment ...
... 15th issue of G&D, Dr. Guillermina Lozano (MD Anderson Cancer ... form of p53 affects oncogenesis, and lends startling new insight ... therapy. , "Our data are both exciting and sobering: we ... to treatment, emphasizes Dr. Lozano. , One function of the ...
... Inc.,(NYSE: NUS ) today announced the board of ... which will be paid on June 18, 2008, to,stockholders ... Nu Skin Enterprises, Inc. is a global direct ... and Europe. The company markets,premium quality personal care products ...
Cached Medicine News:Health News:Research shows HPV testing offers women protection for twice as long as smear testing 2Health News:Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 2Health News:RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS 2
... The Double Aspheric 78D is an ... lens offering an ideal .93x image ... of view. It is optimally designed ... motion of all slit lamps. Available ...
The 40D is ideal for pediatric ophthalmoscopy and other examinations requiring expansive fundus visibility. Alternatively, this lens may be used at the slit lamp biomicroscope to provide an extremely...
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... Automated Urine Microscopy Analyzer (iQ200) uses ... software to classify urine particles into ... The iQ200 eliminates most technologist time ... images by automating specimen preparation, image ...
Medicine Products: